Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank 薬物名(臨床試験情報から抽出) KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 Riboflavin 1件: Riboflavin2件: RIBOFLAVIN; Vitamin B2; --8件: 13, 38, 46, 96, 97, 162, 168, 265
2 Resorcinol -0件: ---
3 Reserpine -0件: ---
4 Rescinnamine -0件: ---
5 Rifampin 1件: Rifampicin2件: Rifampicin; Rifampin; --9件: 6, 13, 17, 46, 84, 86, 93, 299, 338
6 Ramipril 1件: Ramipril1件: Ramipril; 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬7件: 46, 49, 66, 67, 113, 218, 257
7 Ranitidine 1件: Ranitidine1件: Ranitidine; 1件: HRH2 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬2件: 13, 65
8 Ribavirin 1件: Ribavirin2件: Copegus; RIBAVIRIN; --2件: 2, 96
9 Rifabutin 1件: Rifabutin1件: RIFABUTIN; --1件: 96
10 Risperidone 1件: Risperidone1件: Risperidone; 2件: DRD2,
HTR2A 💬
11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬5件: 8, 156, 179, 187, 206
11 Ritonavir 1件: Ritonavir2件: Norvir; Ritonavir; --3件: 2, 86, 265
12 Rofecoxib 1件: Rofecoxib1件: Rofecoxib; 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
13 Repaglinide 1件: Repaglinide1件: Repaglinide; 2件: ABCC8,
KCNJ11 💬
4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬3件: 6, 21, 299
14 Rosiglitazone maleate 1件: Rosiglitazone2件: Rosiglitazone; Rosiglitazone maleate; 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬5件: 46, 75, 97, 222, 265
15 Ranitidine hydrochloride 1件: Ranitidine1件: Ranitidine; 1件: HRH2 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬2件: 13, 65
16 Rizatriptan benzoate -0件: ---
17 Rabeprazole sodium 1件: Rabeprazole1件: Rabeprazole; 2件: ATP4A,
ATP4B 💬
4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬2件: 2, 51
18 Rocuronium bromide 1件: Rocuronium1件: Rocuronium; 16件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB2,
CHRNB3,
CHRNB4 💬
15件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 296
19 Riluzole 1件: Riluzole2件: Rilutek; Riluzole; 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
20 Ropinirole hydrochloride 1件: Ropinirole3件: REQUIP; ROPINIROLE; Ropinirole Hydrochloride; 3件: DRD2,
DRD3,
DRD4 💬
8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬4件: 2, 6, 74, 309
21 Rifapentine -0件: ---
22 Rimantadine hydrochloride -0件: ---
23 Risedronate sodium 1件: Risedronic acid3件: Risedronate; Risedronate Sodium; Risedronic acid; 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬9件: 46, 50, 66, 93, 95, 96, 107, 113, 274
24 Raltitrexed -0件: ---
25 Rebamipide 1件: Rebamipide1件: Rebamipide; --4件: 46, 53, 97, 271
26 Ramatroban 1件: Ramatroban1件: Ramatroban; 2件: PTGDR,
TBXA2R 💬
3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬1件: 13
27 Remifentanil hydrochloride 1件: Remifentanil2件: Remifentanil; Remifentanyl; 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬2件: 6, 70
28 Ritodrine hydrochloride -0件: ---
29 Riboflavin sodium phosphate 1件: Riboflavin2件: RIBOFLAVIN; Vitamin B2; --8件: 13, 38, 46, 96, 97, 162, 168, 265
30 Roxithromycin 1件: Roxithromycin1件: Roxithromycin; --2件: 46, 299
31 Ranimustine -0件: ---
32 Rolipram 1件: Rolipram1件: Rolipram; 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬
5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 8, 13
33 Rokitamycin -0件: ---
34 Riboflavin butyrate 1件: Riboflavin2件: RIBOFLAVIN; Vitamin B2; --8件: 13, 38, 46, 96, 97, 162, 168, 265
35 Rosuvastatin calcium 1件: Rosuvastatin3件: Crestor; Rosuvastatin; ROSUVASTATIN CALCIUM; 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬11件: 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299
36 Reglitazar -0件: ---
37 Raloxifene hydrochloride 1件: Raloxifene2件: Raloxifene; Raloxifene hydrochloride; 2件: ESR1,
ESR2 💬
10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 46
38 Rolitetracycline -0件: ---
39 Rosoxacin -0件: ---
40 Ritodrine -0件: ---
41 Resorcinol monoacetate -0件: ---
42 Rufloxacin -0件: ---
43 Rifamycin -0件: ---
44 Rifalazil -0件: ---
45 Rifaximin 1件: Rifaximin3件: Rifaximin; RIFAXIMINA; Xifaxan; --8件: 6, 65, 93, 94, 96, 97, 99, 296
46 Ravuconazole -0件: ---
47 Rivastigmine tartrate 1件: Rivastigmine3件: EXELON; Rivastigmine; Rivastigmine Transdermal System; 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬3件: 5, 6, 13
48 Rasagiline mesylate 1件: Rasagiline4件: AZILECT; Rasagilina; RASAGILINE; RASAGILINE MESYLATE; 1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬7件: 2, 5, 6, 13, 17, 58, 66
49 Reboxetine mesylate -0件: ---
50 Remoxipride -0件: ---
51 Remoxipride hydrochloride -0件: ---
52 Ramelteon 1件: Ramelteon2件: Ramelteon; ROZEREM; 2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬3件: 6, 8, 46
53 Rimabotulinumtoxin B 1件: Botulinum toxin type B3件: Botulinum toxin type B; NEUROBLOC; RimabotulinumtoxinB; 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬4件: 2, 6, 13, 51
54 Rituximab 1件: Rituximab6件: MabThera; Rituxan; RITUXIMAB; Rixathon; Ruxience; TRUXIMA; 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬49件: 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
55 Rebimastat -0件: ---
56 Rivastigmine 1件: Rivastigmine3件: Exelon; Rivastigmine; Rivastigmine Transdermal System; 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬3件: 5, 6, 13
57 Rubitecan -0件: ---
58 Ropivacaine hydrochloride 1件: Ropivacaine1件: Ropivacaine; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬3件: 36, 46, 70
59 Racemethionine 1件: Methionine3件: Butanoic acid; L-methionine; Methionine; --7件: 34, 75, 84, 93, 229, 298, 300
60 Racepinephrine -0件: ---
61 Raluridine -0件: ---
62 Ramoplanin -0件: ---
63 Ranibizumab 1件: Ranibizumab3件: Lucentis; Ranibizumab; RhuFab V2; 1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬4件: 34, 166, 227, 301
64 Ranolazine 1件: Ranolazine3件: RANEXA; Ranolazina; Ranolazine; --6件: 2, 58, 86, 96, 113, 114
65 Ranolazine hydrochloride 1件: Ranolazine3件: RANEXA; Ranolazina; Ranolazine; --6件: 2, 58, 86, 96, 113, 114
66 Ranpirnase -0件: ---
67 Rasburicase -0件: ---
68 Raxibacumab -0件: ---
69 Regadenoson 1件: Regadenoson1件: Regadenoson; 1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 58
70 Regramostim 1件: Regramostim2件: GM-CSF; RhGM-CSF; 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229
71 Repifermin -0件: ---
72 Retapamulin -0件: ---
73 Reteplase -0件: ---
74 Riboprine -0件: ---
75 Ridogrel -0件: ---
76 Rilapladib -0件: ---
77 Rimexolone -0件: ---
78 Rimonabant 1件: Rimonabant2件: Acomplia; Rimonabant; 1件: CNR1 💬4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 193
79 Ritanserin -0件: ---
80 Rivoglitazone -0件: ---
81 Rizatriptan sulfate -0件: ---
82 Roflumilast 1件: Roflumilast1件: Roflumilast; 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬
5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 84, 299
83 Ronnel -0件: ---
84 Roquinimex -0件: ---
85 Rostaporfin -0件: ---
86 Rotigaptide -0件: ---
87 Rotigotine 1件: Rotigotine3件: NEUPRO; ROTIGOTINA; Rotigotine; 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 127
88 Roxarsone -0件: ---
89 Rufinamide 1件: Rufinamide2件: Inovelon; RUFINAMIDE; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 144
90 Rupintrivir -0件: ---
91 Ruplizumab -0件: ---
92 Renzapride -0件: ---
93 Ranirestat -0件: ---
94 Relacatib -0件: ---
95 Rilonacept 1件: Rilonacept1件: Rilonacept; 2件: IL1A,
IL1B 💬
45件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬4件: 51, 106, 107, 266
96 Romidepsin -0件: ---
97 Rusalatide acetate -0件: ---
98 Raltegravir 1件: Raltegravir2件: ISENTRESS; Raltegravir; --4件: 13, 26, 93, 265
99 Rhubarb -0件: ---
100 Rosin -0件: ---
101 Rociverine -0件: ---
102 Rivaroxaban 1件: Rivaroxaban2件: Rivaroxaban; Xarelto; 1件: F10 💬1件: Complement and coagulation cascades 💬5件: 46, 49, 75, 91, 210
103 Ronifibrate -0件: ---
104 Ritiometan -0件: ---
105 Rupatadine 1件: Rupatadine1件: Rupatadine; 2件: HRH1,
PTAFR 💬
4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬1件: 46
106 Rabeprazole 1件: Rabeprazole1件: Rabeprazole; 2件: ATP4A,
ATP4B 💬
4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬2件: 2, 51
107 Racecadotril -0件: ---
108 Raloxifene 1件: Raloxifene2件: Raloxifene; Raloxifene hydrochloride; 2件: ESR1,
ESR2 💬
10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 46
109 Ramosetron -0件: ---
110 Rasagiline 1件: Rasagiline4件: Azilect; Rasagilina; Rasagiline; Rasagiline mesylate; 1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬7件: 2, 5, 6, 13, 17, 58, 66
111 Raubasine -0件: ---
112 Reboxetine -0件: ---
113 Remifentanil 1件: Remifentanil2件: Remifentanil; Remifentanyl; 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬2件: 6, 70
114 Reproterol -0件: ---
115 Ribostamycin -0件: ---
116 Rilmenidine 1件: Rilmenidine2件: HYPERIUM; Rilmenidine; 3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 8
117 Rimantadine -0件: ---
118 Risedronic acid 1件: Risedronic acid3件: Risedronate; Risedronate Sodium; Risedronic acid; 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬9件: 46, 50, 66, 93, 95, 96, 107, 113, 274
119 Rizatriptan -0件: ---
120 Robenidine -0件: ---
121 Romifidine -0件: ---
122 Ropinirole 1件: Ropinirole3件: Requip; Ropinirole; ROPINIROLE HYDROCHLORIDE; 3件: DRD2,
DRD3,
DRD4 💬
8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬4件: 2, 6, 74, 309
123 Ropivacaine 1件: Ropivacaine1件: Ropivacaine; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬3件: 36, 46, 70
124 Rosiglitazone 1件: Rosiglitazone2件: Rosiglitazone; Rosiglitazone maleate; 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬5件: 46, 75, 97, 222, 265
125 Rosuvastatin 1件: Rosuvastatin3件: Crestor; Rosuvastatin; Rosuvastatin calcium; 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬11件: 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299
126 Roxatidine acetate -0件: ---
127 Ruscogenin -0件: ---
128 Rutoside -0件: ---
129 Ridaforolimus -0件: ---
130 Reparixin 1件: Reparixin1件: Reparixin; 2件: CXCR1,
CXCR2 💬
7件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬2件: 298, 299
131 Reslizumab 1件: Reslizumab1件: Reslizumab; 1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬2件: 44, 98
132 Retosiban -0件: ---
133 Rolofylline -0件: ---
134 Romiplostim 1件: Romiplostim2件: NPLATE; ROMIPLOSTIM; 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬4件: 60, 63, 64, 65
135 Ropidoxuridine -0件: ---
136 Remikiren -0件: ---
137 Raspberry 1件: Raspberry1件: Raspberry; --1件: 97
138 Radezolid -0件: ---
139 Ramucirumab -0件: ---
140 Retaspimycin -0件: ---
141 Riociguat 1件: Riociguat2件: Adempas; RIOCIGUAT; 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬
11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬6件: 51, 84, 86, 88, 225, 299
142 Razupenem -0件: ---
143 Rilotumumab -0件: ---
144 Rindopepimut -0件: ---
145 Rintatolimod -0件: ---
146 Rontalizumab 1件: Rontalizumab1件: Rontalizumab; 13件: IFNA1,
IFNA10,
IFNA13,
IFNA14,
IFNA16,
IFNA17,
IFNA2,
IFNA21,
IFNA4,
IFNA5,
IFNA6,
IFNA7,
IFNA8 💬
25件: Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 49
147 Rozrolimupab -0件: ---
148 Remestemcel-L 1件: Remestemcel-L3件: Adult human mesenchymal stem cells; Prochymal; Remestemcel-L; --3件: 85, 96, 97
149 Rilpivirine -0件: ---
150 Riferminogene pecaplasmid -0件: ---
151 Royal jelly 1件: Royal jelly1件: Royal jelly; --1件: 49
152 Rezatomidine -0件: ---
153 Ruxolitinib 1件: Ruxolitinib1件: Ruxolitinib; 2件: JAK1,
JAK2 💬
35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 228
154 Remogliflozin etabonate -0件: ---
155 Robatumumab -0件: ---
156 Rucaparib -0件: ---
157 Regorafenib -0件: ---
158 Radavirsen -0件: ---
159 Rigosertib 1件: Rigosertib1件: Rigosertib; 1件: PLK1 💬4件: Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 36
160 Romosozumab 1件: Romosozumab2件: Evenity; ROMOSOZUMAB; 1件: SOST 💬2件: Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway 💬1件: 274
161 Rebastinib -0件: ---
162 Ramatercept -0件: ---
163 Rabusertib -0件: ---
164 Radium Ra 223 dichloride -0件: ---
165 Rivipansel -0件: ---
166 Roxadustat -0件: ---
167 Ralimetinib -0件: ---
168 Relamorelin -0件: ---
169 Ricolinostat -0件: ---
170 Rimegepant -0件: ---
171 Rabacfosadine -0件: ---
172 Ralinepag 1件: Ralinepag1件: RALINEPAG; 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
173 Relebactam -0件: ---
174 Rolapitant -0件: ---
175 Rurioctocog alfa pegol 1件: Rurioctocog alfa pegol1件: Rurioctocog alfa pegol; --1件: 288
176 Rasagiline tartrate 1件: Rasagiline4件: Azilect; Rasagilina; Rasagiline; Rasagiline mesylate; 1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬7件: 2, 5, 6, 13, 17, 58, 66
177 Rociletinib -0件: ---
178 Ribociclib -0件: ---
179 Relugolix -0件: ---
180 Recanaclotide -0件: ---
181 Remetinostat -0件: ---
182 Revefenacin -0件: ---
183 Rovalpituzumab tesirine -0件: ---
184 Ropeginterferon alfa-2b -0件: ---
185 Risankizumab 1件: Risankizumab1件: Risankizumab; 1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬4件: 37, 96, 97, 271
186 Ravulizumab 1件: Ravulizumab2件: RAVULIZUMAB; Ultomiris; 1件: C5 💬10件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 2, 11, 13, 50, 62, 66, 109
187 Rimiducid 1件: Rimiducid1件: Rimiducid; 1件: CASP9 💬35件: Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬6件: 19, 60, 65, 284, 285, 326
188 Ribaxamase -0件: ---
189 Rezafungin -0件: ---
190 Ruzasvir -0件: ---
191 Relenopride -0件: ---
192 Roluperidone -0件: ---
193 Reltecimod -0件: ---
194 Ravoxertinib -0件: ---
195 Rivoceranib -0件: ---
196 Reproxalap 1件: Reproxalap1件: Reproxalap; --1件: 160
197 Rovazolac -0件: ---
198 Relacorilant 1件: Relacorilant2件: CORT125134; Relacorilant; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 75
199 Relatlimab -0件: ---
200 Ripretinib -0件: ---
201 Reldesemtiv 1件: Reldesemtiv2件: CK-2127107; RELDESEMTIV; 1件: TNNC2 💬1件: Calcium signaling pathway 💬2件: 2, 3
202 Risdiplam 1件: Risdiplam2件: EVRYSDI; Risdiplam; 1件: SMN2 💬1件: Nucleocytoplasmic transport 💬1件: 3
203 Risuteganib -0件: ---
204 Remdesivir -0件: ---
205 Razuprotafib -0件: ---
206 Ravagalimab 1件: Ravagalimab1件: Ravagalimab; 1件: CD40 💬17件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬2件: 53, 97
207 Romilkimab -0件: ---
208 Racemetyrosine -0件: ---
209 Rovafovir etalafenamide -0件: ---
210 Remimazolam -0件: ---
211 Retifanlimab -0件: ---
212 Rimtuzalcap -0件: ---
213 Ridinilazole -0件: ---
214 Rozanolixizumab 1件: Rozanolixizumab1件: ROZANOLIXIZUMAB; --3件: 11, 14, 63
215 Regdanvimab -0件: ---